📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease. (2018)

First Author: Daroszewska A
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1242/dmm.035576

PubMed Identifier: 30154079

Publication URI: http://europepmc.org/abstract/MED/30154079

Type: Journal Article/Review

Volume: 11

Parent Publication: Disease models & mechanisms

Issue: 9

ISSN: 1754-8403